TMS, Spravato or ketamine: which one fits you?

The question isn’t which treatment is strongest. It’s which one is right for you, after a careful look at your diagnosis, past treatments, health and goals.

Three treatments, side by side

Choose a treatment to follow it across the figure.

How it is given

TMSMagnetic pulses on the scalp
SpravatoNasal spray you take in the clinic
KetamineIV infusion or injection by a clinician

Each visit

TMSAbout 3 to 20 minutes
SpravatoAbout 2 to 2½ hours
KetamineAbout 1 to 1½ hours

Usual start

TMSDaily for about 6 weeks
SpravatoTwice a week for 4 weeks, then weekly
KetamineOften twice a week for 4 weeks

How fast

TMSGradual, over weeks
SpravatoCan help within days
KetamineCan help within days

Driving after

TMSYes
SpravatoNot until the next day, after sleep
KetamineNo; a ride home is needed

Cost

TMSOften covered by insurance
SpravatoOften covered by insurance
KetamineSelf-pay, $400 per treatment

Common side effects

TMSScalp discomfort, headache
SpravatoDissociation, dizziness, nausea, sleepiness, higher blood pressure
KetamineDissociation, nausea, higher blood pressure

FDA status

TMSCleared for depression and OCD
SpravatoApproved for treatment-resistant depression
KetamineOff-label for depression

Deciding together

We look at how fast you need relief, side effects, your schedule, rides, health history and cost, and decide together.

Request a consultation

Insurance coverage depends on your plan and usually needs prior authorization. Our insurance team checks this for you.

They can work together. Treatments aren’t either-or. Medicines usually continue, and some people combine or move between treatments as their needs change.

Good to know. Feeling “floaty” on Spravato or ketamine isn’t required for it to work.

Evidence and references

Evaluation drives the choice

Our clinic’s approach

No single treatment is best for everyone. The choice depends on an accurate diagnosis, a reconstructed treatment history, safety, medical conditions and the person’s goals. The evaluation is as important as the treatment itself. Expected benefit is discussed honestly before starting: some people improve substantially, some partially, and some not enough.

TMS: noninvasive, drug-free

FDA labeling / guidelinesWell established

FDA-cleared for major depression (and OCD). Courses are usually daily for about 6 weeks; sessions range from about 3 minutes (theta burst) to about 20 minutes. Benefit is gradual. Side effects are mostly scalp discomfort and headache; seizure is rare and screened for. It may suit people who prefer to avoid medication side effects or need to keep driving and working.

Esketamine: FDA-approved, REMS-monitored

FDA labeling / guidelinesHuman evidence

Esketamine is one of ketamine’s two mirror-image molecules and acts mainly through the glutamate system. It is FDA-approved for treatment-resistant depression, alone or with an oral antidepressant, and given only in certified settings with at least 2 hours of monitoring. Feeling dissociated is common but is not required for the antidepressant benefit. Insurance often covers it with prior authorization.

Racemic ketamine: off-label, supervised

Human evidenceEvidence mixed

Ketamine is FDA-approved as an anesthetic; for depression it is used off-label, with informed consent, screening and monitoring. A single infusion produced rapid improvement within a day in early trials. Head-to-head trials against esketamine are lacking; indirect comparisons suggest similar or greater benefit, with low certainty. Supervised medical treatment with defined dosing is different from recreational or wellness use. Self-pay: $400 per treatment.

Combining and sequencing treatments

Our clinic’s approach

Medication management often continues alongside TMS or esketamine, and therapy supports recovery. If one approach gives only partial benefit, another may be added or substituted. Progress is measured with standard scales such as the PHQ-9 so decisions are based on data. For severe or life-threatening depression, ECT referral is part of the conversation.

Shared decision-making

Your care team

Key considerations: severity and safety (urgent cases may need faster-acting treatment or a higher level of care); cardiovascular disease or uncontrolled blood pressure (esketamine, ketamine); seizure risk or metal near the head (TMS); substance-use history; pregnancy; time available for visits; transportation; and insurance coverage.

  1. McIntyre et al. 2023, World Psychiatry (TRD consensus)
  2. O’Reardon et al. 2007, Biol Psychiatry
  3. Blumberger et al. 2018, Lancet (THREE-D)
  4. SPRAVATO Prescribing Information, rev. 3/2026
  5. Popova et al. 2019, Am J Psychiatry (TRANSFORM-2)
  6. Zarate et al. 2006, Arch Gen Psychiatry
  7. Bahji et al. 2021, J Affect Disord

This comparison is general. Your care team will recommend what fits you. For education only; this is not medical advice.

The takeaway

  • TMS uses no medicine, and you can drive afterward. Spravato and ketamine are medicines given in the clinic, and you need a ride home.
  • TMS and Spravato are cleared or approved by the FDA for depression. Ketamine for depression is an off-label use.
  • Your evaluation decides which one fits, and treatments can be combined or used one after another.

What you can do next

  1. Think about your schedule, your ride options and your insurance.
  2. Read the two safety guides.
  3. Request a consultation to ask what fits you.

Ready to take the next step?

Your first consultation is an evaluation, not a commitment to any treatment. Our patient advocate calls you back within one business day.

Or call us(571) 378-13986849 Old Dominion Drive, Suite 315, McLean

Read our reviews on Google

Call (571) 378-1398Request a consultation